The Influence of Triclosan on Biomarkers of Cardiovascular Risk in Patients in the Cardiovascular and Periodontal

Mary P Cullinan1,2, Janet E Palmer1, Malcolm J Faddy3

  • 1School of Medicine, The University of Queensland, Brisbane, Australia.

Insights

Triclosan toothpaste may impact cardiovascular disease biomarkers and kidney function in diabetic patients, but its clinical significance remains uncertain. Further research is needed to confirm these findings.

Area of Science:

  • Cardiovascular Medicine
  • Oral Health
  • Pharmacology

Background:

  • Triclosan toothpaste effectively manages plaque, gingivitis, and periodontitis progression.
  • The impact of triclosan on cardiovascular disease (CVD) inflammatory biomarkers, kidney, and liver function is not well-established.

Purpose of the Study:

  • To investigate the effects of triclosan toothpaste on CVD inflammatory biomarkers, kidney function, and liver function over a 5-year period.

Main Methods:

  • A 5-year randomized controlled trial involving 383 patients assigned to triclosan or placebo toothpaste.
  • Biomarkers assessed included lipid profiles, C-reactive protein, erythrocyte sedimentation rate (ESR), white cell count (WCC), estimated glomerular filtration rate (eGFR), and liver function enzymes.
  • Statistical analysis employed mixed models and transition modeling, accounting for covariates like age, sex, diabetes, and medication use.

Main Results:

  • Triclosan toothpaste significantly decreased total cholesterol (TC), LDL cholesterol, and HDL cholesterol compared to placebo.
  • ESR showed a slower rate of increase in the triclosan group, particularly in males on statins.
  • Diabetic patients using placebo toothpaste were more likely to experience eGFR deterioration than those using triclosan.

Conclusions:

  • Triclosan toothpaste may influence certain CVD inflammatory biomarkers and kidney function in diabetic individuals.
  • No significant impact was observed on liver function.
  • The clinical significance of these observed influences requires further investigation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
941
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K